in the diagnostic criteria applied, the dates the studies were conducted, and the age ranges for which prevalences are reported. These would need addressing in any attempt to synthesize data into a single national prevalence. Furthermore, it is likely that many (probably most) studies are designed to be targeting a specific subgroup of the population (as can be seen by reviewing the titles of prevalence studies in the current manuscript -refs 18-28). Synthesizing data from such studies to derive a national estimate, which is the stated primary aim of the review, would require statistical methods to weight each estimate according to its relative contribution to the overall South African population. This is unlikely to be possible without significant work. Unless the authors can develop a statistical strategy to address this, I would recommend that a narrative description should be the primary aim. Page 2, line 12. 'The purpose of this review is estimate'. Please insert 'to' after 'review'.
The introduction refers to IDF global estimates from 2013, but more up to date IDF estimates should be used. The text goes on to say that Africa will bear the brunt of a global increase in the number of people with diabetes. Africa may have the largest relative increase, but will only account for a relatively small proportion of the global increase in numbers. The next statement about underestimation by the IDF because of undiagnosed diabetes is not correct, as the IDF data account for high rates of undiagnosed diabetes in Africa. The proposed search strategy (table 1) does not attempt to restrict the findings to studies reporting on prevalence or epidemiology in any way. This seems to risk capturing far too many titles. Data extraction should include response rates. The 'Characteristics of cases' seems unusual. It is the characteristics of the study population, not just those with diabetes that counts. This should include ethnicity.
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